Ram Prasad Sahu

All stories by Ram Prasad Sahu

New businesses to boost growth momentum of Tata Consumer Products

New businesses to boost growth momentum of Tata Consumer Products

Rediff.com7 Dec 2023

The stock of fast-moving consumer goods major Tata Consumer Products has been reaching new all-time highs on better-than-expected results for the July-September quarter (second quarter, or Q2), strong growth in the food business, and margin gains in the beverage/international business. Most brokerages are positive on the stock, given growth prospects, and believe that rich valuations are justified. The near-term trigger has been the robust operational performance in Q2.

From Bajaj to TVS, two-wheeler makers hit full throttle on growth prospects

From Bajaj to TVS, two-wheeler makers hit full throttle on growth prospects

Rediff.com4 Dec 2023

With sentiment for the automotive (auto) sector turning positive, stocks of two-wheeler auto majors have been hitting their 52-week highs. Hero MotoCorp, Bajaj Auto, TVS Motor Company, and Eicher Motors recently reached their yearly highs on strong sales in the festival season and the expectation of faster growth rates ahead. Since the start of this month, listed two-wheeler majors have delivered returns in the 12-17 per cent range, compared to the 7 per cent gains for the S&P BSE Auto Index and 3 per cent for the benchmark S&P BSE Sensex.

Near-term headwinds may delay UPL recovery

Near-term headwinds may delay UPL recovery

Rediff.com23 Nov 2023

UPL, the country's largest agrochemical company, had a weak July-September quarter (Q2), reporting a sharp fall in revenues across geographies. Overall, the revenues were down 19 per cent on the back of lower agrochemical prices and inventory destocking. While the overall volumes were down 7 per cent, prices fell by 15 per cent. Volume decline in the European market was on the back of high channel inventory and product bans while in India the fall by 27 per cent was on account of muted demand for segments such as cotton and pulses.

Growth and margin uptick critical for gains in Divi's Laboratories

Growth and margin uptick critical for gains in Divi's Laboratories

Rediff.com17 Nov 2023

Rise in input costs, inventory write-off, and pricing pressures led to a drop in gross margins. Higher competitive pressures led to cuts in operating profit margins and earnings estimates for FY24 and FY25. Most brokerages have a 'neutral' or a 'reduce' rating on the stock on account of valuations.

Global demand headwinds could weigh on Bharat Forge, says analysts

Global demand headwinds could weigh on Bharat Forge, says analysts

Rediff.com16 Nov 2023

Even though Bharat Forge's performance in the July-September quarter broadly met Street estimates and defence orders are on the rise, the subdued outlook for its global business has prompted some brokerages to adopt a cautious stance on the company. Analysts have reduced the company's earnings per share (EPS) estimates to account for the slow recovery of its overseas subsidiaries. Valuations are also trading at long-term averages, which could limit potential upsides.

Strong near-term outlook to aid IndiGo's revenue growth

Strong near-term outlook to aid IndiGo's revenue growth

Rediff.com15 Nov 2023

InterGlobe Aviation, the operator of India's leading airline IndiGo, delivered a better than expected performance across most parameters in Q2FY24. The company posted its fourth consecutive quarter of net profit of Rs 188 crore. It had reported a loss of Rs 1,583 crore in the same quarter a year ago.

Sun Pharmaceutical's vital signs: A strong dose of valuation multiples

Sun Pharmaceutical's vital signs: A strong dose of valuation multiples

Rediff.com13 Nov 2023

Bolstered by an impressive performance in the global specialty business and outstanding results in the Indian market, Sun Pharmaceutical Industries, the largest pharmaceutical (pharma) company in the country, showcased a strong performance in the July-September quarter (second quarter, or Q2) of 2023-24 (FY24).

US sales momentum, margin gains to support pharma major Cipla's stock

US sales momentum, margin gains to support pharma major Cipla's stock

Rediff.com8 Nov 2023

A strong performance in the July-September quarter of 2023-24 (Q2FY24), an upward revision in the margin guidance and sustained momentum in US sales has helped the stock of pharmaceutical major Cipla gain about 2 per cent over the last two trading sessions. The brokerages have upgraded the earnings estimates for this financial year (FY24) by 6-9 per cent to factor in the improved margin guidance and sales in the US market. Led by the US market, which rose by 31 per cent, the company posted a 16 per cent growth in revenues.

Sluggish volumes likely to cap upsides in Colgate-Palmolive stock

Sluggish volumes likely to cap upsides in Colgate-Palmolive stock

Rediff.com6 Nov 2023

The Colgate-Palmolive (India) stock gained 2.3 per cent in trade on Friday, and ended at Rs 2,079 per share. This was on the back of a robust operating performance in the July-September quarter of 2023-24 (Q2FY24) and expectations of gradual sales recovery going ahead. While the stock is up 44 per cent from its lows in January this year, further gains will depend on its ability to sustain higher growth rates.

Aurobindo Pharma: Strong prospects offset by valuation concerns

Aurobindo Pharma: Strong prospects offset by valuation concerns

Rediff.com2 Nov 2023

Since the start of this financial year (FY24), the stock of Aurobindo Pharma has been one of the top pharma gainers, enhancing investor wealth by over 68 per cent, with a third of those gains coming in the last three months. The stock is riding on multiple triggers given its investments in the production-linked incentive or PLI scheme, biosimilars, injectables and vaccines, which should drive revenues and profits over the medium term. Better than expected performance after the June quarter results led to a revision of earnings estimates for FY24 and FY25.

ER&D software firms navigate Q2 bends with growth arrows in sight

ER&D software firms navigate Q2 bends with growth arrows in sight

Rediff.com30 Oct 2023

The July-September quarter results of software companies in the engineering research and development (ER&D) segment were broadly in line with expectations, though there have been cuts in revenue growth guidance. While results were a mixed bag, and there are cautionary views on the near-term outlook, brokerages and global consulting firms highlight the strong growth trajectory for the sector. They expect this segment of the software sector to grow by 8-12 per cent going forward.

Chemical stocks may underperform; brokerages stay cautious

Chemical stocks may underperform; brokerages stay cautious

Rediff.com27 Oct 2023

Since their highs in September, chemical stocks have underperformed the benchmarks and broader indices over the past month with larger players witnessing a 9-22 per cent fall during this period. Expectations of weak September quarter results amid high inventory, demand woes and weak realisations have led to the underperformance.

Hotel stocks to ride the elevator to revenue growth on room rates

Hotel stocks to ride the elevator to revenue growth on room rates

Rediff.com23 Oct 2023

Hotel companies, which have experienced substantial share price gains in the past six months, are not only expected to post robust revenue growth in the seasonally weak July-September quarter (second quarter, or Q2) of 2023-24 (FY24), with the trend continuing in the second half (H2) of FY24, but according to some analysts, they will also benefit from a structural uptrend in progress. To begin with, larger players in the listed hotel sector are expected to report strong growth in Q2 compared to the year-ago quarter. Led by higher demand from the business segment, the sector is expected to achieve a growth rate of 15-30 per cent.

Weak demand puts a crack on India's leading listed tile makers' prospects

Weak demand puts a crack on India's leading listed tile makers' prospects

Rediff.com23 Oct 2023

Kajaria Ceramics, the country's leading listed tile manufacturer, has seen its stock fall by 7 per cent over the past month amid concerns about rising input costs and sluggish domestic demand. Other listed stocks also experienced weakness in September, although there was some recovery in October. While strong exports are expected to help stabilise domestic market prices, the surge in gas prices over the past couple of months may have impacted margins in the second half of FY24.

Movie success offsets ad revenue slip for broadcasters like ZEE, Sun TV

Movie success offsets ad revenue slip for broadcasters like ZEE, Sun TV

Rediff.com19 Oct 2023

Notwithstanding record revenues in certain media sectors like film exhibition in the July-September quarter (second quarter, or Q2), the operational performance of the broadcasting business remained subdued. Zee Entertainment Enterprises and Sun TV are expected to experience a year-on-year (Y-o-Y) decline in advertising (ad) revenues during this period. Conversely, box office (BO) collections are anticipated to exceed Rs 3,000 crore in the quarter, propelled by a series of successful movie releases.

Valuation hurdle, competition may cap upside for Dixon Technologies

Valuation hurdle, competition may cap upside for Dixon Technologies

Rediff.com17 Oct 2023

The stock of Dixon Technologies (India), the country's largest listed electronic manufacturing services (EMS) player, was up 6 per cent in 10 trading sessions, boosting the gains over the last three months to 21 per cent. The gains came following reports that Dixon will produce laptops in India in partnership with US and Chinese firms under the production-linked investment (PLI) scheme. It recently signed an agreement to make smartphones for Xiaomi India.

Robust Q2, demand trends to put out welcome mat for realty stocks

Robust Q2, demand trends to put out welcome mat for realty stocks

Rediff.com16 Oct 2023

The S&P BSE Realty Index has emerged as one of the top-performing sectors, yielding a remarkable 45 per cent return over the past six months. The three leading players, listed by market capitalisation, have substantially enriched investor wealth by 43-70 per cent during this period. If the second quarter (Q2) of 2023-24 (FY24) updates from Macrotech Developers (Lodha) and Sobha, along with industry data for the quarter, serve as any indication, the trend of strong bookings for larger players is expected to continue.

Sluggish rural demand, weak volumes dent Marico's stock in Q2

Sluggish rural demand, weak volumes dent Marico's stock in Q2

Rediff.com13 Oct 2023

A muted revenue performance in the September quarter and weak management commentary weighed on the stock of consumer major Marico which shed 8.5 per cent to Rs 542 from its intraday highs on Tuesday. The company indicated that demand trends were similar to that of the June quarter with instances of increasing food prices and below-normal rainfall distribution in some regions impeding the anticipated recovery in rural demand.

Rising costs, competition leave paint sector in need of fresh coat

Rising costs, competition leave paint sector in need of fresh coat

Rediff.com9 Oct 2023

While the four largest listed paint companies have seen marginal negative returns, the S&P BSE Fast Moving Consumer Goods (FMCG) and the National Stock Exchange Nifty FMCG indices have delivered a solid 16 per cent return during the same period. Initially, volume growth and reduced costs bolstered the sector's sentiment, but brokerages have grown cautious due to increased competitive pressures.

Margin recovery key for Blue Dart Express stock, volume growth expected

Margin recovery key for Blue Dart Express stock, volume growth expected

Rediff.com5 Oct 2023

Brokerages lowered their earnings estimates following muted results in Q1FY24. While analysts remain optimistic about the stock's medium-term prospects, they highlight near-term concerns stemming from lower realisations due to changes in the product mix and margin pressures resulting from new plane additions.

Prev  |  Next